CD274 and neoplasm: Monotherapy with anti–PD-1 or anti–PD-L1 was not effective in preventing tumor development because the tumor size averaged 508 ± 356 mm3 and 500 ± 208 mm3, respectively, whereas mice receiving EV alone or in combination with checkpoint blockade antibodies had tumors with an average size smaller than 100 mm3.